International | Select other Country

Receive the full KiSel-10 Study Article

 

Thank you for visiting the Pharma Nord web site.

KiSel-10 is a randomized double-blind placebo-controlled
study with 443 elderly Swedish study participants.
The study showed statistically significant results.

Please choose your country of residence below to receive the
KiSel-10 Study Article.

 

To the frontpage

Pharma Nord develops, manufactures and markets clinically documented dietary supplements, herbal remedies and medicine based on optimal bioavailability, safety and documentation.

Address 

Pharma Nord B.V.
Editiestraat 9
1321 NG ALMERE
Nederland

Opening Hours 

Monday - Friday: 9am and 11am EST at

+31 35 54 30 991  

              
  
 
GlobalSign